← Back to directory

George Coukos

Researcher Next ID · RN-029825

Researcher · Immunology and Microbiology

Ludwig Cancer Research

Brussels, Switzerland

Not currently recruitingFunding unknown
Works count
882
Citation count
67,425
H-index
113
i10-index
366

Research interests

Immunology and Microbiology
Medicine
Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
Immune Cell Function and Interaction
Monoclonal and Polyclonal Antibodies Research

Publications

  • Interpretation of T cell states from single-cell transcriptomics data using reference atlases

    Nature Communications · 2021 · 10.1038/s41467-021-23324-4

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer · 2020 · https://doi.org/10.1136/jitc-2019-000337

  • Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

    Cell · 2020 · https://doi.org/10.1016/j.cell.2020.09.015

  • Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion

    Nature Immunology · 2020 · 10.1038/s41590-020-0793-3

  • Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

    Cancer Cell · 2019 · 10.1016/j.ccell.2019.05.004

  • Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

    Nature Reviews Clinical Oncology · 2019 · https://doi.org/10.1038/s41571-019-0218-0

  • Consensus guidelines for the use and interpretation of angiogenesis assays

    Angiogenesis · 2018 · 10.1007/s10456-018-9613-x

  • Interrogating open issues in cancer precision medicine with patient-derived xenografts

    Nature reviews. Cancer · 2017 · https://doi.org/10.1038/nrc.2016.140

  • Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

    Nature reviews. Cancer · 2015 · https://doi.org/10.1038/nrc4019

  • Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers

    Cancer Cell · 2015 · 10.1016/j.ccell.2015.09.006

  • Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors

    Nature Medicine · 2014 · 10.1038/nm.3541

  • Deciphering and Reversing Tumor Immune Suppression

    Immunity · 2013 · 10.1016/j.immuni.2013.07.005

  • Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors

    Cancer Research · 2013 · 10.1158/0008-5472.can-12-4100

  • T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis

    Cancer Research · 2012 · 10.1158/0008-5472.can-11-3687

  • Cancer immunotherapy comes of age

    Nature · 2011 · https://doi.org/10.1038/nature10673

  • Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis

    Gynecologic Oncology · 2011 · 10.1016/j.ygyno.2011.09.039

  • Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

    Nature · 2011 · 10.1038/nature10169

  • Rethinking ovarian cancer: recommendations for improving outcomes

    Nature reviews. Cancer · 2011 · https://doi.org/10.1038/nrc3144

  • Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

    Blood · 2009 · 10.1182/blood-2009-03-208249

  • Modulation of the antitumor immune response by complement

    Nature Immunology · 2008 · 10.1038/ni.1655

  • The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

    Nature Cell Biology · 2008 · 10.1038/ncb1681

  • Laser-capture microdissection

    Nature Protocols · 2006 · 10.1038/nprot.2006.85

  • microRNAs exhibit high frequency genomic alterations in human cancer

    Proceedings of the National Academy of Sciences · 2006 · 10.1073/pnas.0508889103

  • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

    Nature Medicine · 2004 · https://doi.org/10.1038/nm1093

  • Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

    New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa020177

  • Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

    PubMed · 2001

Current projects

    No projects listed.